ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study
European Urology
◽
10.1016/j.eururo.2021.09.016
◽
2021
◽
Author(s):
Cristina Masini
◽
Cinzia Iotti
◽
Ugo De Giorgi
◽
Roberto Salvatore Bellia
◽
Sebastiano Buti
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Stereotactic Body Radiotherapy
◽
Renal Cell
◽
Pretreated Patients
Download Full-text
Related Documents
Cited By
References
Re: Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study
European Urology
◽
10.1016/j.eururo.2021.11.003
◽
2021
◽
Author(s):
Mathieu Spaas
◽
Nora Sundahl
◽
Piet Ost
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Stereotactic Body Radiotherapy
◽
Renal Cell
◽
Pretreated Patients
Download Full-text
Re: Cristina Masini, Cinzia Iotti, Ugo De Giorgi, et al. Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.09.016
European Urology
◽
10.1016/j.eururo.2021.11.034
◽
2022
◽
Author(s):
Giulio Francolini
◽
Lucia P. Ciccone
◽
Lorenzo Livi
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Stereotactic Body Radiotherapy
◽
Renal Cell
◽
Pretreated Patients
Download Full-text
Re: Cristina Masini, Cinzia Iotti, Ugo De Giorgi, et al. Nivolumab in Combination with Stereotactic Body Radiotherapy in Pretreated Patients with Metastatic Renal Cell Carcinoma. Results of the Phase II NIVES Study. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.09.016
European Urology
◽
10.1016/j.eururo.2021.11.035
◽
2022
◽
Author(s):
Ye Lei
◽
Yong Zhang
◽
Nianzeng Xing
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Stereotactic Body Radiotherapy
◽
Renal Cell
◽
Pretreated Patients
Download Full-text
NIVES study: A phase II trial of nivolumab (NIVO) plus stereotactic body radiotherapy (SBRT) in II and III line of patients (pts) with metastatic renal cell carcinoma (mRCC).
Journal of Clinical Oncology
◽
10.1200/jco.2018.36.15_suppl.tps4602
◽
2018
◽
Vol 36
(15_suppl)
◽
pp. TPS4602-TPS4602
◽
Cited By ~ 1
Author(s):
Cristina Masini
◽
Cinzia Iotti
◽
Patrizia Ciammella
◽
Roberta Gnoni
◽
Annalisa Berselli
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Stereotactic Body Radiotherapy
◽
Renal Cell
◽
Phase Ii Trial
Download Full-text
Faculty Opinions recommendation of Phase II placebo-controlled randomized discontinuation trial of sorafenib in patients with metastatic renal cell carcinoma.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.14342.471834
◽
2006
◽
Author(s):
Robert Figlin
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Randomized Discontinuation Trial
Download Full-text
RANDOMIZED PHASE II STUDY OF FIRST-LINE EVEROLIMUS (EVE) + BEVACIZUMAB (BEV) VERSUS INTERFERON ALFA-2A (IFN) + BEV IN PATIENTS (PTS) WITH METASTATIC RENAL CELL CARCINOMA (MRCC): RECORD-2
Annals of Oncology
◽
10.1093/annonc/mds399
◽
2012
◽
Vol 23
◽
pp. ix258
◽
Cited By ~ 24
Author(s):
A. Ravaud
◽
C. Barrios
◽
Ö. Anak
◽
D. Pelov
◽
A. Louveau
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase Ii Study
◽
Interferon Alfa
◽
First Line
◽
Randomized Phase Ii
Download Full-text
Phase II Trial of Low Dose γ -Interferon in Metastatic Renal Cell Carcinoma
The Journal of Urology
◽
10.1016/s0022-5347(17)32587-9
◽
1994
◽
Vol 152
(3)
◽
pp. 841-845
◽
Cited By ~ 32
Author(s):
Julie A. Ellerhorst
◽
Robert G. Kilbourn
◽
Robert J. Amato
◽
Alexander A. Zukiwski
◽
Elaine Jones
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Low Dose
◽
Phase Ii Trial
◽
Γ Interferon
Download Full-text
Cyclic Interf eron Alpha Treatment in Metastatic Renal Cell Carcinoma: Results of a Phase II Study and Review of the Literature
Urologia Internationalis
◽
10.1159/000282937
◽
1997
◽
Vol 58
(1)
◽
pp. 8-12
◽
Cited By ~ 4
Author(s):
Georg Hofmockel
◽
Winfried Tack
◽
Hubert G.W. Frohmüller
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase Ii Study
◽
Review Of The Literature
Download Full-text
An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma
Cancer Chemotherapy and Pharmacology
◽
10.1007/s00280-010-1262-8
◽
2010
◽
Vol 66
(6)
◽
pp. 1065-1070
◽
Cited By ~ 6
Author(s):
Seiji Naito
◽
Taiji Tsukamoto
◽
Michiyuki Usami
◽
Hiroyuki Fujimoto
◽
Hideyuki Akaza
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Early Phase
◽
Phase Ii Trial
◽
Japanese Patients
Download Full-text
A phase II trial of first-line sorafenib in patients with metastatic renal cell carcinoma unwilling to receive or with early intolerance to immunotherapy: SOGUG Study 06-01
Clinical & Translational Oncology
◽
10.1007/s12094-010-0544-2
◽
2010
◽
Vol 12
(7)
◽
pp. 503-508
◽
Cited By ~ 9
Author(s):
Joaquim Bellmunt
◽
Pablo Maroto-Rey
◽
José M. Trigo
◽
Joan Carles
◽
Vicente Guillem
◽
...
Keyword(s):
Renal Cell Carcinoma
◽
Cell Carcinoma
◽
Phase Ii
◽
Metastatic Renal Cell Carcinoma
◽
Renal Cell
◽
Phase Ii Trial
◽
First Line
◽
To Receive
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close